Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 52 citing articles:

Focus on the Dynamics of Neutrophil-to-Lymphocyte Ratio in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-Analysis and Systematic Review
Yusheng Guo, Dongqiao Xiang, Jiayu Wan, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5297-5297
Open Access | Times Cited: 33
Platelet‐to‐lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study
Hongling Wang, Li Li, Yi Ma
Clinical Cardiology (2023) Vol. 46, Iss. 6, pp. 632-638
Open Access | Times Cited: 16
A potential tumor marker: Chaperonin containing TCP‑1 controls the development of malignant tumors (Review)
Liming Zheng, Xingyue Chen, Li Zhang, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 3
Open Access | Times Cited: 13
Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non‐small‐cell lung cancer with bone metastasis
Yohei Asano, Norio Yamamoto, Satoru Demura, et al.
Cancer Medicine (2023) Vol. 12, Iss. 11, pp. 12425-12437
Open Access | Times Cited: 12
Association of systemic inflammatory indices with anthropometric measures, metabolic factors, and liver function in non-alcoholic fatty liver disease
Sara Arefhosseini, Taha Aghajani, Helda Tutunchi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Predictive Value of Neutrophil‐to‐Lymphocyte Ratio for Immune Checkpoint Inhibitor‐Related Myocarditis Among Patients Treated for Non‐Small‐Cell Lung Cancer
Xue Jian, Chuanbin Liu, Jun Shao, et al.
Cancer Innovation (2025) Vol. 4, Iss. 2
Open Access
Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment
Liangshan Da, Ziting Qu, Congjun Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Clinical impact of inflammatory and nutrition index based on metabolic tumor activity in non‑small cell lung cancer treated with immunotherapy
Koki Ito, Kousuke Hashimoto, Kyoichi Kaira, et al.
Oncology Letters (2024) Vol. 27, Iss. 3
Open Access | Times Cited: 3
Prognostic value of the geriatric nutritional risk index and other hematological markers on long‐term survival in the geriatric population
Jarson Pedro da Costa Pereira, Alcides da Silva Diniz, Maria Conceição Chaves de Lemos, et al.
Geriatrics and gerontology international/Geriatrics & gerontology international (2024) Vol. 24, Iss. 3, pp. 312-318
Closed Access | Times Cited: 3
Role of platelet-to-lymphocyte ratio at the time of arrival to the emergency room as a predictor of short-term mortality in trauma patients with severe trauma team activation
Jae Kwang Kim, Kyung Hoon Sun
Acute and Critical Care (2024) Vol. 39, Iss. 1, pp. 146-154
Open Access | Times Cited: 3
The advanced lung cancer inflammation index (ALI) predicted the postoperative survival rate of patients with non-small cell lung cancer and the construction of a nomogram model
Shixin Ma, Z.-S. Li, Lunqing Wang
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed
Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 25, pp. 2567-2578
Open Access | Times Cited: 7
Prognostic value of tumor‑associated CD177+ neutrophils in lung adenocarcinoma
Jinhua Zhou, Qingxia Xu, Huan Liu, et al.
Oncology Letters (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 2
Potential predictors of the pathologic response after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a narrative review
Kyoichi Kaira, Yoshinobu Ichiki, Hisao Imai, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 5, pp. 1137-1149
Open Access | Times Cited: 2
From Tumor Macroenvironment to Tumor Microenvironment: The Prognostic Role of the Immune System in Oral and Lung Squamous Cell Carcinoma
Rosa Alessia Battista, Giacomo Maria Pini, A Finco, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2759-2759
Open Access | Times Cited: 2
The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non‐small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores
Josh McGovern, Fraser O'Rourke, Sarah Will, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 2
Real‑world evaluation of the efficacy of immune checkpoint inhibitors in the treatment of metastatic breast cancer
Xiaoyan Qian, Yunxia Tao, Haizhu Chen, et al.
Oncology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Nomogram for Predicting Survival Post-Immune Therapy in Cholangiocarcinoma Based on Inflammatory Biomarkers
Jianan Jin, Haibo Mou, Yibin Zhou, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma
Michel Bila, Amelie Franken, Jeroen Van Dessel, et al.
Oral Oncology (2023) Vol. 149, pp. 106664-106664
Closed Access | Times Cited: 6
Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in non-small cell lung cancer
Mesut Bayraktaroğlu, Pınar Yildiz
Medicine (2023) Vol. 102, Iss. 26, pp. e34180-e34180
Open Access | Times Cited: 5
Immune Checkpoint Inhibitors in “Special” NSCLC Populations: A Viable Approach?
Giuseppe Bronte, Donato Michele Cosi, Chiara Magri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12622-12622
Open Access | Times Cited: 5
Real world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancer
Madeline MacDonald, Darin Poei, Alexis Leyba, et al.
Cancer Treatment and Research Communications (2023) Vol. 36, pp. 100752-100752
Open Access | Times Cited: 4
The effect of platelet-to-lymphocyte ratıo (PLR) and glasgow prognostıc score (GPS) on recurrence, and survıval ın patıents undergoıng lobectomy for early-stage non-small cell lung cancer (NSCLC)
Bahar Ağaoğlu Şanlı, Barış Gülmez, Serkan Yazgan, et al.
Updates in Surgery (2023) Vol. 76, Iss. 2, pp. 631-639
Closed Access | Times Cited: 4
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: Markers predicting immune-checkpoint inhibitor efficacy and immune-related adverse events
Qiuyu Jiang, Ruyi Xue
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 3, pp. 577-582
Open Access | Times Cited: 1
Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma
Ye Wang, Yingqiu Song, Runze Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top